EUROFINS SCIENTIFIC SE - Q1 ORGANIC REVENUE GROWTH OF 7.1% IN CORE BUSINESS (EXCLUDING COVID-19 RELATED CLINICAL TESTING AND REAGENT ...
確定! 回上一頁